ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ニザチジン

Nizax

HCID 3033637
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
76963-41-2
標準SMILES
CN/C(=C\[N+](=O)[O-])NCCSCc1csc(CN(C)C)n1
InChIKey
SGXXNSQHWDMGGP-IZZDOVSWSA-N
分子式
C12H21N5O2S2
平均分子量
331.5 g/mol

概要

Nizatidine is a member of the class of 1,3-thiazoles having a dimethylaminomethyl substituent at position 2 and an alkylthiomethyl moiety at position 4. It has a role as a H2-receptor antagonist, a cholinergic drug and an anti-ulcer drug. It is an organic sulfide, a carboxamidine, a C-nitro compound, a member of 1,3-thiazoles and a tertiary amino compound.

名称と識別子

優先名称
Nizax
IUPAC
(E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
現地名
ニザチジン
英語名
Nizatidine
分子式
C12H21N5O2S2
分子量
331.46

名称と別名

NizaxZanizalZE-101MFCD00865660ZL-101(E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamineN-(2-(((2-((Dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamineNCGC00016934-01C12H21N5O2S2CAS-76963-41-2(E)-N-(2-(((2-((dimethylamino)methyl)thiazol-4-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine(E)-1-N'-[2-[[2-[(dimethylamino)methyl]-1,3-thiazol-4-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine
名称をさらに表示
N-[2-(2-ジメチルアミノメチル-4-チアゾリルメチルチオ)エチル]-N'-メチル-2-ニトロビニリデンジアミンニザチジンドルセンチザノンアシノンニザチンニザノンニザトリックニザメルクアテミノンN-[2-[[[2-[(ジメチルアミノ)メチル]-4-チアゾリル]メチル]チオ]エチル]-N'-メチル-2-ニトロ-1,1-エテンジアミンN-[2-[2-(ジメチルアミノメチル)-4-チアゾリルメチルチオ]エチル]-N'-メチル-2-ニトロエテン-1,1-ジアミンニザチジン (JP17)N-[2-[2-(ジメチルアミノメチル)-4-チアゾリルメチルチオ]エチル]-N′-メチル-2-ニトロエテン-1,1-ジアミンジメチル[(4-{[(2-{[1-(メチルアミノ)-2-ニトロエテニル]アミノ}エチル)スルファニル]メチル}-1,3-チアゾール-2-イル)メチル]アミンN-[2-(2-ジメチルアミノメチル-4-チアゾリルメチルチオ)エチル]-N′-メチル-2-ニトロビニリデンジアミン

物性

構造計算による物性

XLogP
1.6
極性表面積
140 Ų
水素結合供与体数
2
水素結合受容体数
8
回転可能結合数
9
重原子数
21
形式電荷
0
複雑度
349

実験および物理化学的性質

Drugs · 2 件

Pharmaceuticals -> Gastric and Ulcer Drugs

Pharmaceuticals -> Listed in ZINC15

LogP1.1
Solubility · 3 件

10-33mg/mL

3.86e-02 g/L

>49.7 [ug/mL] (The mean of the results at pH 7.4)

Melting Point · 2 件

130-132 °C

203 °C

Physical DescriptionSolid
Collision Cross Section · 3 件

168.4 Ų [M+H]+ [CCS Type: TW; Method: Major Mix IMS/Tof Calibration Kit (Waters)]

168 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

169.1 Ų [M+H]+ [CCS Type: TW; Method: calibrated with polyalanine and drug standards]

物理化学的性質

融点
130 · 130-1320C
沸点
478.2 · 478.2±45.0 °C(Predicted)
比重(密度)
1.249 · 1.249±0.06 g/cm3(Predicted)
貯蔵温度
Keep in dark place,Inert atmosphere,Room temperature

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

wgk
3
rtecs
KM6565000
毒性
LD50 in mice, rats (mg/kg): 265, >300 i.v.; 1685, 1680 orally (Pioch)
hs_code
29349990
risk_code
22
hazard_code
Xn
safety_code
36
Hazard Classifications
Acute Tox. 4 Oral
ストレージクラス
11 - Combustible Solids
有毒物質データの
76963-41-2(Hazardous Substances Data)

化学と産業

薬理情報

Protein Binding35%
Pharmacodynamics · 1 件

Nizatidine is a competitive, reversible inhibitor of histamine at the histamine H2-receptors, particularly those in the gastric parietal cells. By inhibiting the action of histamine on stomach cells, nizatidine reduces stomach acid production. Nizatidine had no demonstrable antiandrogenic action. Full-dose therapy for the problems treated by nizatidine lasts no longer than 8 weeks. It has been demonstrated that treatment with a reduced dose of nizatidine is effective as maintenance therapy following healing of active duodenal ulcers.

Mechanism of Action · 1 件

Nizatidine competes with histamine for binding at the H<sub>2</sub>-receptors on the gastric basolateral membrane of parietal cells. Competitive inhibition results in reduction of basal and nocturnal gastric acid secretions. The drug also decreases the gastric acid response to stimuli such as food, caffeine, insulin, betazole, or pentagastrin.

Biological Half-Life1-2 hours
Metabolism/Metabolites · 1 件

Hepatic. Less than 7% of an oral dose is metabolized as N2-monodes-methylnizatidine, an H2-receptor antagonist, which is the principal metabolite excreted in the urine. Other likely metabolites are the N2-oxide (less than 5% of the dose) and the S-oxide (less than 6% of the dose).

Absorption, Distribution and Excretion · 3 件

Rapid (bioavailability of nizatidine exceeds 70%)

0.8 to 1.5 L/kg

40-60 L/h

Cellular LocationsCytoplasm
Metabolite PathwaysNizatidine Action Pathway
応用分野 · 4 件

関連反応

5 件
反応記録を作成
HRID 1108848 の反応式
HRID 1108848反応物として
HRID 1108849 の反応式
HRID 1108849生成物として
HRID 1108850 の反応式
HRID 1108850生成物として
HRID 1108851 の反応式
HRID 1108851生成物として
HRID 1602592 の反応式
HRID 1602592生成物として

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
N-[2-[[[2-[(ジメチルアミノ)メチル]-4-チアゾリル]メチル]チオ]エチル]-N′-メチル-2-ニトロ-1,1-エテンジアミン
axid
Nizaxi
Acinon
gastrax
nizaxid
Tizanon
dimethyl[(4-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}-1,3-thiazol-2-yl)methyl]amineN'-[2-[[[2-[(Dimethylamino)methyl]-4-thiazolyl]methyl]thio]ethyl]-N-methyl-2-nitro-1,1-ethenediamineSMR000466384Acinon (TN)Axid (TN)Nizatidine (Standard)Prestwick2_000921SCHEMBL769

データベース識別子

CAS
76963-41-2
PubChem CID
3033637
ChEBI
CHEBI:7601
Nikkaji
J32.887A
溶解性
水に溶けにくく、メタノールに溶ける。
酸解離定数(Pka)
2.1 · 2.1, 6.8(at 25℃)
外見
Solid
色
オフホワイトからペールイエロー
水溶解度
21.4 g/L · 21.4g/L(温度表記なし)
Merck
14 · 14,6660
InChI
InChI=1S/C12H21N5O2S2/c1-13-11(6-17(18)19)14-4-5-20-8-10-9-21-12(15-10)7-16(2)3/h6,9,13-14H,4-5,7-8H2,1-3H3
InChIKey
SGXXNSQHWDMGGP-UHFFFAOYSA-N
SMILES
C(NCCSCC1=CSC(CN(C)C)=N1)(NC)=C[N+]([O-])=O
CAS データベース
76963 · 76963-41-2(CAS DataBase Reference)

化学的性質

化学的特性White Crystalline Powder

用途ヒスタミンH2 受容体遮断剤 です。胃粘膜のヒスタミンH2受容体を遮断し、 胃酸分泌を抑制作用を示します。

説明Nizatidine is the fifth H2-antagonist introduced to the world market as an antiulcer agent. It is reported to be effective in the treatment of both duodenal and gastric ulcers or the prevention of their recurrences. Given once-daily, nizatidine’s bioavailability is not diminished by the concurrent administration of an antacid.

使用Nizatidine is used for treating stomach and duodenum ulcers and other conditions accompanied by elevated acidity of the gastrointestinal tract.

一般的な説明Nizatidine, N-[2-[[[2-(dimethylamino)methyl]-4-thiazolyl]methyl]thio]-ethyl]-N'-methyl-2-nitro-1,1-ethenediamine (Axid), is an off-white to buff crystallinesolid that is soluble in water, alcohol, and chloroform. It isa thaizole derivative of raniditine and has pKas of 2.1 (side chain) and 6.8 (dimethylamino). Nizatidine’s mechanism ofaction is similar to other H2-antagonists, as is its receptor selectivity.It is more potent than cimetidine.Nizatidine has excellent oral bioavailability (>90%).The effects of antacids or food on its bioavailability arenot clinically significant. The elimination half-life is 1 to2 hours. It is excreted primarily in the urine (90%) andmostly as unchanged drug (60%). Metabolites include nizatidinesulfoxide (6%), N-desmethylnizatidine (7%), andnizatidine N-oxide (dimethylaminomethyl function).Nizatidine has no demonstrable antiandrogenic action, effectson other hormones, or inhibitory effects on cytochromeisozymes involved in the metabolism of other drugs.

上流・下流製品情報

上流原料

ジヒドリド硫黄DimethylamineEエチレンジアミン (無水)ニトロメタン1,3-ジクロロ-2-プロパノン2-Dimethylaminomethyl-4-Chloromethyl-4-hydrony thiazolineチアゾリジン2,4-ジアミノアゾベンゼン·塩酸塩Dimethyl aminothic acetamide1-ビニルピレンDimethyl amino acetenitrile酢酸エチル2-Dimethyl amino methyl-4-chloro methyl thiazole HClメタノールAnhydrous pyridineシクロヘキサノン1,1-ビス(メチルチオ)-2-ニトロエチレンヨードメタンシアン化カリウム1-アミノエタノールメチルアミン2-(ニトロメチレン)チアゾリジン

補足説明

定義ChEBI: A member of the class of 1,3-thiazoles having a dimethylaminomethyl substituent at position 2 and an alkylthiomethyl moiety at position 4.